Attenuation of lipopolysaccharide-induced acute lung injury after (pro)renin receptor blockade

Experimental Lung Research

Volumn 41, Issue 4, 2015, Pages 199-207

  Ishii, Kenjiro ^a   Takeuchi, Hiroya ^a   Fukunaga, Koichi ^a   Hirano, Yuki ^a   Suda, Koichi ^a   Hagiwara, Tomoko ^a   Miyasho, Taku ^b   Yamada, Shingo ^c   Nakamura, Rieko ^a   Takahashi, Tsunehiro ^a   Wada, Norihito ^a   Kawakubo, Hirofumi ^a   Saikawa, Yoshiro ^a   Omori, Tai ^a   Betsuyaku, Tomoko ^a   Ichihara, Atsuhiro ^d   Kitagawa, Yuko ^a  

^a KEIO UNIVERSITY   (Japan)

^b RAKUNO GAKUEN UNIVERSITY   (Japan)

^c SHINO TEST CORPORATION   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

(pro)renin receptor blocker; Acute lung injury; Prorenin; Reninangiotensin system

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PRORENIN RECEPTOR BLOCKER; RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ATP6AP2 PROTEIN, RAT; AUTACOID; CELL SURFACE RECEPTOR; CYTOKINE; ENDOTOXIN; ENDOTOXIN, ESCHERICHIA COLI; PEPTIDE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONTROLLED STUDY; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; LUNG LAVAGE; LUNG PARENCHYMA; MALE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; BRONCHOALVEOLAR LAVAGE FLUID; CELL PROTECTION; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; LUNG; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PNEUMONIA; PULMONARY EDEMA; SPRAGUE DAWLEY RAT;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; CYTOPROTECTION; DISEASE MODELS, ANIMAL; ENDOTOXINS; INFLAMMATION MEDIATORS; LUNG; MALE; NEUTROPHIL INFILTRATION; PEPTIDES; PNEUMONIA; PROTON-TRANSLOCATING ATPASES; PULMONARY EDEMA; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE;

EID: 84928480404     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2014.993444     Document Type: Article

References (32)

1. Wyncoll DL, Evans TW: Acute respiratory distress syndrome. Lancet. 1999;354:497-501.
2. Lehr HA, Bittinger F, Kirkpatrick CJ: Microcirculatory dysfunction in sepsis: A pathogenetic basis for therapy? J Pathol. 2000;190:373-386.
3. Riedemann NC, Guo RF, Ward PA: The enigma of sepsis. JClin Invest. 2003;112:460-467.
4. Abd el-Aziz MA, Othman AI, Amer M, El-Missiry MA: Potential protective role of angiotensin converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats. J Appl Toxicol. 2001;21:469-473.
5. Griffin KA, Abu-Amarah I, Picken M, Bidani AK: Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent. Hypertension. 2003;41:201-206.
6. Stojiljkovic L, Behnia R: Role of renin angiotensin system inhibitors in cardiovascular and renal protection: A lesson from clinical trials. Curr Pharm Des. 2007;13:1335-1345.
7. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J: Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003;35:881-900.
8. Jerng JS, Yu CJ, Wang HC, Chen KY, Cheng SL, Yang PC: Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome. Crit Care Med. 2006;34:1001-1006.
9. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM: Angiotensin converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436:112-116.
10. Suzuki F, Hayakawa M, Nakagawa T, Nasir UM, Ebihara A, Iwasawa A, Ishida Y, Nakamura Y, Murakami K: Human prorenin has "gate and handle" regions for its non-proteolytic activation. J Biol Chem. 2003;278:22217-22222.
11. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Nakagawa T, Nishiyama A, Kawachi H, Shimizu F, Inagami T: Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol. 2006;17:2495-2503.
12. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer J-D: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109:1417-1427.
13. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, Koura Y, Nishiyama A, Okada H, Uddin MN, Nabi AH, Ishida Y, Inagami T, Saruta T: Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle"region for non-proteolytic activation of prorenin. J Clin Invest. 2004;114:1128-1135.
14. Kinouchi K, Ichihara A, Itoh H: Functional characterization of (pro)renin receptor in association with V-ATPase. Front Biosci (Landmark Ed). 2011;16:3216-3223.
15. Kinouchi K, Ichihara A, Sano M, Sun-Wada GH, Wada Y, Itoh H: The (pro)renin receptor/ATP6AP2 is essential for vacuolar H+-ATPase assembly in murine cardiomyocytes. Circ Res. 2010;107:30-34
16. NurunNabi AHM, Biswas KB, Nakagawa T, Ichihara A, Inagami T, Suzuki F: 'Decoy peptide' region (RIFLKRMPSI) of prorenin prosegment plays a crucial role in prorenin binding to the (pro)renin receptor. Int J Mol Med. 2009;24:83-89.
17. NurunNabi AHM, Biswas KB, Nakagawa T, Ichihara A, Inagami T, Suzuki F: Prorenin has high affinity multiple binding sites for (pro)renin receptor. Biochim Biophys Acta. 2009;1794:1838-1847.
18. Ichihara A, Sakoda M, Kurauchi-Mito A, Narita T, Kinouchi K, Itoh H: Drug discovery for overcoming chronic kidney disease (CKD): New therapy for CKD by a (pro)renin-receptorblocking decoy peptide. J Pharmacol Sci. 2009;109:20-23.
19. Ichihara A, Sakoda M, Kurauchi-Mito A, Narita T, Kinouchi K, Bokuda K, Itoh H: New approaches to blockade of the renin-angiotensin-aldosterone system: Characteristics and usefulness of the direct renin inhibitor aliskiren. J Pharmacol Sci. 2010;113:296-300.
20. Hirano Y, Takeuchi H, Suda K, Hagiwara T, Miyasho T, Kawamura Y, Yamada S, Oyama T, Takahashi T, Wada N, Saikawa Y, Ichihara A, Kitagawa Y: (Pro)renin receptor blocker improves survival of rats with sepsis. J. Surg Res. 2013 in press.
21. Zhang H, Sun GY: LPS induces permeability injury in lung microvascular endothelium via AT(1) receptor. Arch Biochem Biophys. 2005;441:75-83.
22. Hagiwara S, Iwasaka H, Matumoto S, Hidaka S, Noguchi T: Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models. Crit Care Med. 2009 Feb;37:626-633.
23. Arndt PG, Young SK, Poch KR, Nick JA, Falk S, Schrier RW, Worthen GS: Systemic inhibition of the angiotensin-converting enzyme limits lipopolysaccharide-induced lung neutrophil recruitment through both bradykinin and angiotensin II-regulated pathways. J Immunol. 2006;177:7233-7241.
24. Bhatia M, Moochhala S: Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol. 2004;202:145-156.
25. Seki H, Fukunaga K, Arita M, Arai H, Nakanishi H, Taguchi R, Miyasho T, Takamiya R, Asano K, Ishizaka A, Takeda J, Levy BD: The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J Immunol. 2010;184:836-843
26. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ: HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000;165:2950-2954.
27. Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M, Kobayashi A, Maruyama I, Yamada S, Hasegawa N, Soejima J, Koh H, Ishizaka A: Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med. 2004;170:1310-1316.
28. Wang H, Yang H, Tracey KJ: Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med. 2004;255:320-331.
29. Genctoy G, Altun B, Kiykim A, Arici M, Erdem Y, Caʇlarg M, Yasavul U, Turgan C, Caʇlar S: TNF alpha-308 genotype and renin-angiotensin system in hemodialysis patients: an effect on inflammatory cytokine levels? Artif. Organs. 2005;29:174-178.
30. Satofuka S, Ichihara A, Nagai N, Koto T, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Itoh H, Oike Y, Ishida S: Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Invest Ophthalmol Vis Sci. 2007;48:422-429.
31. Zhang J, Noble NA, Border WA, Owens RT, Huang Y: Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells. Am J Physiol Endocrinol Metab. 2008;295:E810-E819.
32. Luetscher JA, Kraemer FB, Wilson DM, Schwartz HC, Bryer-Ash M: Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N Engl J Med. 1985;312:1412-1417.